Emmaus Life Sciences Inc. (EMMA) Stock Price & Overview

NASDAQ:EMMA

2.77

-1.72 (-38.31%)

At close: Sep 10, 2019

2.73

-0.04 (-1.44%)

After Hours: 9/10/2019, 8:00:00 PM

Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

The current stock price of EMMA is 2.77 null. Today EMMA is down by -38.31%. In the past month the price decreased by -30.75%.

EMMA Key Statistics

1-Month Range2.49 - 4.5

Market Cap: 131.484M
P/E: N/A
Fwd P/E: N/A
EPS (TTM): -11.16
Dividend Yield: N/A

EMMA Stock Performance

Today

-38.31%

1 Week

-23.69%

1 Month

-30.75%

3 Months

N/A

Longer-term

6 Months N/A

1 Year N/A

2 Years N/A

3 Years N/A

5 Years N/A

10 Years N/A

EMMA Stock Chart

Emmaus Life Sciences Inc. / EMMA Daily stock chart

EMMA Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to EMMA.

Chartmill TA Rating

Chartmill Setup Rating

EMMA Full Technical Analysis Report

EMMA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to EMMA. EMMA may be in some trouble as it scores bad on both profitability and health.

Chartmill FA Analysis

Valuation

Growth

Profitability

Health

Dividend

EMMA Full Fundamental Analysis Report

EMMA Earnings

Next Earnings DateN/A

Last Earnings DateN/A

EMMA Earnings History

EMMA Forecast & Estimates

Analysts

Analysts100

Price TargetN/A

EPS Next Y50.09%

Revenue Next YearN/A

EMMA Forecast & Estimates

EMMA Financial Highlights

Over the last trailing twelve months EMMA reported a non-GAAP Earnings per Share(EPS) of -11.16. The EPS increased by 26.19% compared to the year before.

Income Statements

Revenue(TTM)1.32M

Net Income(TTM)-9.60M

		Industry Rank	Sector Rank
PM (TTM)	-729.66%
ROA	-220.74%
ROE	-570.03%
Debt/Equity	0.37

Chartmill High Growth Momentum

EPS Q2Q%N/A

Sales Q2Q%N/A

EPS 1Y (TTM)26.19%

Revenue 1Y (TTM)923.74%

EMMA financials

EMMA Ownership

Ownership

Inst Owners0.13%

Shares47.47M

Float30.38M

Ins Owners46.21%

Short Float %0.4%

Short Ratio1.42

EMMA Ownership

About EMMA

Company Profile

Emmaus Life Sciences Inc. is a commercial-stage biopharmaceutical company. It is engaged in the discovery, development, marketing and sale of treatments and therapies, for rare and orphan disease categories. Emmaus Life Sciences Inc., formerly known MYnd Analytics Inc., is based in Torrance, United States.

Company Info

Emmaus Life Sciences Inc.

21250 Hawthorne Boulevard Suite 800

Torrance CA 90503

CEO: George C. Carpenter

Phone: 310-214-0065

Emmaus Life Sciences Inc. / EMMA FAQ

What does EMMA do?

What is the stock price of Emmaus Life Sciences Inc. today?

The current stock price of EMMA is 2.77 null. The price decreased by -38.31% in the last trading session.

What is the dividend status of Emmaus Life Sciences Inc.?

EMMA does not pay a dividend.

What is the ChartMill rating of Emmaus Life Sciences Inc. stock?

EMMA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.

Can you provide the PE ratio for EMMA stock?

Emmaus Life Sciences Inc. (EMMA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-11.16).

What is Emmaus Life Sciences Inc. worth?

Emmaus Life Sciences Inc. (EMMA) has a market capitalization of 131.48M null. This makes EMMA a Micro Cap stock.